Manager, Pediatric Clinical Pharmacy Services and Program Director, PGY2 Ped Oncology Pharm Residency
Memorial Sloan Kettering Cancer Center
Dr. Jennifer Thackray is the Manager of Pediatric Pharmacy Clinical Services and the Program Director of a PGY2 Pediatric Oncology Residency at Memorial Sloan Kettering Cancer Center Kids (MSK Kids) in New York, NY. Dr. Thackray earned her Doctor of Pharmacy degree from the University of Oklahoma College of Pharmacy and went on to complete an ASHP-accredited PGY1 Pharmacy Practice Residency (2010) and a PGY2 Pediatric Pharmacotherapy Specialty Residency (2011) at the University of North Carolina Health Clinics in Chapel Hill, NC. Dr. Thackray is board-certified in oncology and pediatric pharmacotherapy. Dr. Thackray joined the MSK Department of Pharmacy in 2011, initially practicing in the pediatric oncology inpatient setting. Over her tenure at MSK, Dr. Thackray has assisted in developing pediatric clinical services in the outpatient hematologic malignancies clinic, precepted and mentored residents, and served as a research advisor for PGY2 resident research projects. Dr. Thackray's clinical interests and research efforts encompass pediatric oncology, supportive care measures (e.g., chemotherapy-induced nausea and vomiting, venous thromboembolism, menstrual suppression), pharmacogenomics, and the development of clinical guidelines within international organizations. She is a member of the Board of Directors for The Pediatric Pharmacy Association (PPA), the Children’s Oncology Group (COG) Pharmacy Steering Committee, and the MSK Medical Staff Advisory Council. She is passionate about increasing and improving interdisciplinary efforts to optimize pediatric oncology care across the healthcare system. Dr. Thackray received the 2021 Ralph D. Bienfang Outstanding Practitioner Award from the Alumni Affairs Board of the University of Oklahoma College of Pharmacy. Dr. Thackray is an active member of the American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), COG, Clinical Pharmacogenetics Implementation Consortium (CPIC), Hematology/Oncology Pharmacy Association (HOPA), and PPA.